AVXL Crosses Above Average Analyst Target
February 05, 2021 at 09:00 AM EST
In recent trading, shares of Anavex Life Sciences Corp (AVXL) have crossed above the average analyst 12-month target price of $13.75, changing hands for $14.89/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..